Premier Pharmacy Labs has voluntarily recalled several lots of injectable drug products, primarily opioid pain relievers, due to possible microbial contamination, the Food and Drug Administration announced yesterday. Hospitals and other health care facilities should stop using and return any recalled products to the company as described in a certified letter sent to all affected customers. Any adverse reactions or quality problems experienced with the products may be reported to the FDA's MedWatch program.

Related News Articles

Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.
Headline
The Food and Drug Administration plans to revise its 2016 draft compounding guidance for hospital and health system pharmacies.
Headline
The Food and Drug Administration Friday released draft guidance on how drug developers can apply for the agency’s Competitive Generic Therapies designation.
Headline
Members of the pharmaceutical distribution supply chain, including dispensers such as hospitals and pharmacies, can apply through March 11 to participate in a…
Headline
The U.S. District Court for the Western District of Pennsylvania has entered a consent decree prohibiting Ranier’s Rx Laboratory Inc. from manufacturing or…
Headline
The Food and Drug Administration Friday warned physicians and patients who use medical devices to monitor levels of the blood thinner warfarin that certain…